[{"Assets_0_Q3_USD":992607000.0,"CommonStockSharesConverted_0_Q3_shares":141027487.0,"CommonStockSharesOutstanding_0_Q3_shares":141027487.0,"EarningsPerShareBasic_1_Q3_USD":-0.4,"EarningsPerShareBasic_3_Q3_USD":-1.04,"NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":-138901000.0,"NetIncomeLossConverted_1_Q3_USD":-55998000.0,"NetIncomeLossConverted_3_Q3_USD":-145941000.0,"RevenuesConverted_1_Q3_USD":39467000.0,"RevenuesConverted_3_Q3_USD":116414000.0,"StockholdersEquity_0_Q3_USD":651509000.0,"StockholdersEquityConverted_0_Q3_USD":651543000.0,"Ticker":"ADPT","CIK":"1478320","name":"ADAPTIVE BIOTECHNOLOGIES CORP","OfficialName":"Adaptive Biotechnologies Corporation Common Stock","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1463975665.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20211103"}]